Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicaid
3
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
trump administration
3
×
wisconsin blog main
wisconsin top stories
alex azar
biogen
medicare
nancy pelosi
aducanumab
affordable care act
aldeyra therapeutics
alliance for aging research
alzheimer's disease
amgen
bayer
bill &
What
drug
3
×
administration
aducanumab
alzheimer’s
amyloid
anathema
angry
angst
anti
awaited
bagged
benefited
billions
bio
biogen
biogen’s
brammer
democrat
despite
details
effects
elements
failure
fear
felt
house
industry
leaked
long
look
losing
lost
lower
monday
nash
news
night
pharma
plan
plans
Language
unset
Current search:
medicaid
×
drug
×
" trump administration "
×
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
